Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133–46.
Ceuleers H, Van Spaendonk H, Hanning N, Heirbaut J, Lambeir AM, Joossens J, et al. Visceral hypersensitivity in inflammatory bowel ailments and irritable bowel syndrome: the position of proteases. World J Gastroenterol. 2016;22(47):10275–86.
Greenwood-van Meerveld B. Significance of 5-hydroxytryptamine receptors on intestinal afferents within the regulation of visceral sensitivity. Neurogastroenterol Motil. 2007;19(Suppl 2):13–8.
Simrén M, Törnblom H, Palsson OS, van Tilburg MAL, Van Oudenhove L, Tack J, et al. Visceral hypersensitivity is related to GI symptom severity in practical GI problems: constant findings from 5 completely different affected person cohorts. Intestine. 2018;67(2):255–62.
Crişan IM, Dumitraşcu DL. Irritable bowel syndrome: peripheral mechanisms and therapeutic implications. Clujul Med. 2014;87(2):73–9.
Lovell RM, Ford AC. World prevalence of and threat elements for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–e7214.
Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, et al. Irritable bowel syndrome prognosis and administration: a simplified algorithm for medical follow. United Eur Gastroenterol J. 2017;5(6):773–88.
Balmus IM, Cojocariu RO, Ciobica A, Strungaru S, Strungaru-Jijie R, Cantemir A, et al. Preliminary examine on the tears oxidative stress standing and sleep disturbances in irritable bowel syndrome sufferers. Oxid Med Cell Longev. 2020;2020:4690713.
Damiani CR, Benetton CA, Stoffel C, Bardini KC, Cardoso VH, Di Giunta G, et al. Oxidative stress and metabolism in animal mannequin of colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol. 2007;22(11):1846–51.
Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, et al. Lipid peroxidation and plasma antioxidant micronutrients in Crohn illness. Am J Clin Nutr. 2001;74(2):259–64.
Li Q, Zhang C, Zhu M, Shan J, Qian H, Ma Y, et al. W-GA nanodots restore intestinal barrier capabilities by regulating flora disturbance and relieving extreme oxidative stress to alleviate colitis. Acta Biomater. 2024;182:260–74.
Chen T, Wang J, Wang YQ, Chu YX. Present understanding of the neural circuitry within the Comorbidity of Persistent Ache and anxiousness. Neural Plast. 2022;2022:4217593.
Guo Q, Lin H, Chen P, Tan S, Wen Z, Lin L, et al. Dynamic modifications of intestinal flora in sufferers with irritable bowel syndrome mixed with anxiousness and melancholy after oral administration of enterobacteria capsules. Bioengineered. 2021;12(2):11885–97.
Auwerx J. Nuclear receptors. I. PPAR gamma within the gastrointestinal tract: achieve or ache? Am J Physiol Gastrointest Liver Physiol. 2002;282(4):G581–5.
Ma L, Li Ok, Wei W, Zhou J, Li Z, Zhang T, et al. Train protects aged mice towards coronary endothelial senescence through FUNDC1-dependent mitophagy. Redox Biol. 2023;62:102693.
Wang J, Xue X, Zhao X, Luo L, Liu J, Dai S, et al. Forsythiaside A alleviates acute lung harm by inhibiting irritation and epithelial barrier damages in lung and colon by PPAR-γ/RXR-α advanced. J Adv Res. 2024;60:183–200.
Smith EM, Bridges CM, Kanzawa G, Knoerl R, Kelly JP 4th, Berezovsky A, et al. Most cancers treatment-related neuropathic ache syndromes–epidemiology and remedy: an replace. Curr Ache Headache Rep. 2014;18(11):459.
van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic ache within the basic inhabitants: a scientific evaluate of epidemiological research. Ache. 2014;155(4):654–62.
Hasegawa-Moriyama M, Kurimoto T, Nakama M, Godai Ok, Kojima M, Kuwaki T, et al. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory ache by the induction of heme oxygenase-1 in macrophages. Ache. 2013;154(8):1402–12.
Fu J, Zhao B, Ni C, Ni H, Xu L, He Q, et al. Rosiglitazone alleviates mechanical Allodynia of rats with Bone Most cancers Ache by the activation of PPAR-γ to inhibit the NF-κB/NLRP3 Inflammatory Axis in spinal twine neurons. PPAR Res. 2021;2021:6086265.
Athnaiel O, Cantillo S, Paredes S, Knezevic NN. The position of Intercourse hormones in Ache-related situations. Int J Mol Sci. 2023;24(3):1866.
Webster J. Moral and Animal Welfare Issues in relation to Species Choice for Animal Experimentation. Anim (Basel). 2014;4(4):729–41.
Al-Chaer ED, Kawasaki M, Pasricha PJ. A brand new mannequin of continual visceral hypersensitivity in grownup rats induced by colon irritation throughout postnatal improvement. Gastroenterology. 2000;119(5):1276–85.
Fan F, Tang Y, Dai H, Cao Y, Solar P, Chen Y, et al. Blockade of BDNF signalling attenuates continual visceral hypersensitivity in an IBS-like rat mannequin. Eur J Ache. 2020;24(4):839–50.
Devall AJ, Santos JM, Fry JP, Honour JW, Brandão ML, Lovick TA. Elevation of mind allopregnanolone slightly than 5-HT launch by brief time period, low dose fluoxetine remedy prevents the estrous cycle-linked enhance in stress sensitivity in feminine rats. Eur Neuropsychopharmacol. 2015;25(1):113–23.
Scholl JL, Afzal A, Fox LC, Watt MJ, Forster GL. Intercourse variations in anxiety-like behaviors in rats. Physiol Behav. 2019;211:112670.
Moloney RD, O’Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral ache: towards animal fashions of irritable-bowel syndrome and related comorbidities. Entrance Psychiatry. 2015;6:15.
Piche T. Tight junctions and IBS–the hyperlink between epithelial permeability, low-grade irritation, and symptom technology? Neurogastroenterol Motil. 2014;26(3):296–302.
Black CJ, Ford AC. World burden of irritable bowel syndrome: developments, predictions and threat elements. Nat Rev Gastroenterol Hepatol. 2020;17(8):473–86.
Fuentes IM, Christianson JA. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil. 2016;28(11):1613–8.
Ravnefjord A, Brusberg M, Larsson H, Lindström E, Martínez V. Results of Pregabalin on visceral ache responses and colonic compliance in rats. Br J Pharmacol. 2008;155(3):407–16.
Achitei D, Ciobica A, Balan G, Gologan E, Stanciu C, Stefanescu G. Completely different profile of peripheral antioxidant enzymes and lipid peroxidation in energetic and non-active inflammatory bowel illness sufferers. Dig Dis Sci. 2013;58(5):1244–9.
Cojocariu RO, Balmus IM, Lefter R, Ababei DC, Ciobica A, Hritcu L et al. Behavioral and oxidative stress modifications in mice subjected to mixtures of a number of stressors related to irritable bowel syndrome. 2020;10(11):865.
Zhang C, Li Q, Xing J, Yang Y, Zhu M, Lin L, et al. Tannic acid and zinc ion coordination of nanase for the remedy of inflammatory bowel illness by selling mucosal restore and eradicating reactive oxygen and nitrogen species. Acta Biomater. 2024;177:347–60.
Deng C, Zhang H, Li Y, Cheng X, Liu Y, Huang S, et al. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis remedy. J Colloid Interface Sci. 2024;671:354–73.
Mete R, Tulubas F, Oran M, Yılmaz A, Avci BA, Yildiz Ok, et al. The position of oxidants and reactive nitrogen species in irritable bowel syndrome: a possible etiological rationalization. Med Sci Monit. 2013;19:762–6.
Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Scientific Providers Committee of the British Society of Gastroenterology. Pointers on the irritable bowel syndrome: mechanisms and sensible administration. Intestine. 2007;56(12):1770–98.
Money BD, Epstein MS, Shah SM. A Novel Supply System of Peppermint Oil is an efficient remedy for irritable bowel syndrome signs. Dig Dis Sci. 2016;61(2):560–71.
Asadi-Shahmirzadi A, Mozaffari S, Sanei Y, Baeeri M, Hajiaghaee R, Monsef-Esfahani HR et al. Advantage of Aloe vera and Matricaria recutita combination in rat irritable bowel syndrome: Mixture of antioxidant and spasmolytic results. Chin J Integr Med. 2012 Dec 21.
Chen Q, Ren Y, Lu J, Bartlett M, Chen L, Zhang Y, et al. A novel prebiotic mix product prevents irritable bowel syndrome in mice by enhancing intestine microbiota and modulating Immune Response. Vitamins. 2017;9(12):1341.
Ponferrada A, Caso JR, Alou L, Colón A, Sevillano D, Moro MA, et al. The position of PPARgamma on restoration of colonic homeostasis after experimental stress-induced irritation and dysfunction. Gastroenterology. 2007;132(5):1791–803.
Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology. 2003;124(5):1265–76.
Chen Y, Yang B, Stanton C, Ross RP, Zhao J, Zhang H, et al. Bifidobacterium pseudocatenulatum ameliorates DSS-Induced colitis by sustaining intestinal mechanical barrier, blocking Proinflammatory cytokines, inhibiting TLR4/NF-κB signaling, and altering intestine microbiota. J Agric Meals Chem. 2021;69(5):1496–512.
Jain V, Jaggi AS, Singh N. Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol Res. 2009;59(6):385–92.
Giordano TJ, Haugen BR, Sherman SI, Shah MH, Caoili EM, Koenig RJ. Pioglitazone remedy of PAX8-PPARγ Fusion protein thyroid carcinoma. J Clin Endocrinol Metab. 2018;103(4):1277–81.
Bian J, Zhang B, Zhang Y, Tian Y, Yin L, Zou W. FGF 10 inhibited spinal microglial activation in Neuropathic Ache through PPAR-γ/NF-κB signaling. Neuroscience. 2022;500:52–62.
Khasabova IA, Khasabov SG, Olson JK, Uhelski ML, Kim AH, Albino-Ramírez AM, et al. Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic ache by defending towards oxidative stress. Ache. 2019;160(3):688–701.
Chia JSM, Farouk AAO, Mohamad TAST, Sulaiman MR, Zakaria H, Hassan NI, et al. Zerumbone ameliorates Neuropathic Ache signs through cannabinoid and PPAR Receptors Utilizing in Vivo and in Silico Fashions. Molecules. 2021;26(13):3849.
Churi SB, Abdel-Aleem OS, Tumber KK, Scuderi-Porter H, Taylor BK. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to quickly inhibit neuropathic ache in rats. J Ache. 2008;9(7):639–49.
Li D, He L, Yuan C, Ai Y, Yang JJ. Peroxisome proliferator-activated receptor gamma agonist pioglitazone alleviates hemorrhage-induced thalamic ache and neuroinflammation. Int Immunopharmacol. 2023;124:110991. Pt B).
Lyons DN, Zhang L, Danaher RJ, Miller CS, Westlund KN. PPARγ agonists attenuate Trigeminal Neuropathic Ache. Clin J Ache. 2017;33(12):1071–80.
Saber MM, Mahmoud MM, Amin HM, Essam RM. Therapeutic results of mixing curcumin and swimming in osteoarthritis utilizing a rat mannequin. Biomed Pharmacother. 2023;166:115309.
Staudacher HM, Black CJ, Teasdale SB, Mikocka-Walus A, Keefer L. Irritable bowel syndrome and psychological well being comorbidity – method to multidisciplinary administration. Nat Rev Gastroenterol Hepatol. 2023;20(9):582–96.
Olden KW, Drossman DA. Psychologic and psychiatric features of gastrointestinal illness. Med Clin North Am. 2000;84(5):1313–27.
Halliwell B. Free radicals and antioxidants – quo vadis? Traits Pharmacol Sci. 2011;32(3):125–30.
Savolainen KM, Loikkanen J, Eerikäinen S, Naarala J. Glutamate-stimulated ROS manufacturing in neuronal cultures: interactions with lead and the cholinergic system. Neurotoxicology 1998 Aug-Oct;19(4–5):669–74.
Hovatta I, Juhila J, Donner J. Oxidative stress in anxiousness and comorbid problems. Neurosci Res. 2010;68(4):261–75.
Aoun P, Watson DG, Simpkins JW. Neuroprotective results of PPARgamma agonists towards oxidative insults in HT-22 cells. Eur J Pharmacol. 2003;472(1–2):65–71.
Domi E, Uhrig S, Soverchia L, Spanagel R, Hansson AC, Barbier E, et al. Genetic deletion of neuronal PPARγ enhances the emotional response to acute stress and exacerbates anxiousness: an Impact reversed by rescue of Amygdala PPARγ operate. J Neurosci. 2016;36(50):12611–23.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The Security, Tolerability and Dangers Related to using newer technology antidepressant medication: a crucial evaluate of the literature. Psychother Psychosom. 2016;85(5):270–88.
Stoetzer C, Papenberg B, Doll T, Völker M, Heineke J, Stoetzer M, et al. Differential inhibition of cardiac and neuronal na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine. Eur J Pharmacol. 2016;783:1–10.
Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and most cancers mortality threat: a meta-analysis. Atherosclerosis. 2017;259:75–82.
Zamani B, Tabatabizadeh SM, Gilasi H, Yazdani S. Results of pioglitazone and linagliptin on glycemic management, lipid profile and hs-CRP in metformin-treated sufferers with sort 2 diabetes: a comparative examine. Horm Mol Biol Clin Investig. 2023;44(4):385–91.
